Milli Gupta, MD, FRCPC, is the Director of Gut Motility Centre, Lead of Southern Alberta Eosinophilic Esophagitis Program, and Director of Southern Alberta and Calgary Barrett’s Esophagus Program. Dr Gupta obtained her medical degree from University of Western Ontario. She completed her residency in Internal Medicine and in Gastroenterology at the University of Alberta. She completed Advanced Esophageal Diseases and GI Neoplasia Fellowships at the Mayo Clinic in Rochester, Minnesota, USA.

I have/had an affiliation (financial or otherwise) with a for-profit or not-for-profit organization.
- Member of an advisory board or speakers’ bureau: AstraZeneca, AVIR Pharma Inc, Eupraxia, Pentax, Sanofi, Regeneron Pharmaceutical Inc.
- Received/will receive a grant or an honorarium from a for-profit or not-for-profit organization: AstraZeneca, AVIR Pharma Inc, Eupraxia, Pentax, Sanofi, Regeneron Pharmaceutical Inc.
- Currently participating, or have participated, in a clinical trial within the past two years: Bristol Myers Squibb, Celldex, Dr. Falk, Eupraxia, Uniquity, ALK pharma, Sanofi Regeneron Pharma Inc

I intend to make therapeutic recommendations for medications that have not received regulatory approval (ie, “off-label” use of medications).